Progyny, Inc. (NASDAQ:PGNY) Receives $48.30 Consensus PT from Analysts

Shares of Progyny, Inc. (NASDAQ:PGNY – Get Free Report) have been given a consensus rating of “Buy” by the ten brokerages that are currently covering the stock, MarketBeat.com reports. Ten equities research analysts have rated the stock with a buy recommendation. The average 1 year target price among brokers that have updated their coverage on […]

Related Keywords

United States ,Michaele Sturmer ,Davidj Schlanger ,Leerink Partnrs ,Securities Exchange Commission ,Lazard Asset Management ,Barclays ,Riverpark Advisors ,Acadian Asset Management ,Keycorp ,Progyny Inc ,Nasdaq ,International Assets Investment Management ,Progyny Company Profile ,Get Free Report ,Chairman David ,Exchange Commission ,President Michael ,Park Advisors ,Asset Management ,Get Free ,Progyny Daily ,Progyny ,Nasdaq Pgny ,Epgny ,Medical ,Ratings ,Consensus ,